Invivyd, Inc. (IVVD) income statement
IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3052% below fair value
$0.47−0.04 (-8.21%)
Close on Nov 18, 2026Market cap $138.68MP/E –Yield –
Invivyd, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -192.8%
- Net margin
- -183.9%
- Return on equity, FY2025
- -34.0%
Financial strength
- Current ratio
- 5.87
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 515.9%
Valuation
- P/E ratio
- –
- Price to sales
- 2.38
- Price to book
- 0.77
- Dividend yield
- –
See a number that looks wrong?